Cargando…
Tricyclic antidepressants and selective serotonin reuptake inhibitors but not anticonvulsants ameliorate pain, anxiety, and depression symptoms in an animal model of central post-stroke pain
BACKGROUND: Central post-stroke pain (CPSP) is a type of neuropathic pain caused by dysfunction in the spinothalamocortical pathway. However, no animal studies have examined comorbid anxiety and depression symptoms. Whether the typical pharmacological treatments for CPSP, which include antidepressan...
Autores principales: | Shyu, Bai Chuang, He, Alan BH, Yu, Ying H, Huang, Andrew Chih Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679055/ https://www.ncbi.nlm.nih.gov/pubmed/34903115 http://dx.doi.org/10.1177/17448069211063351 |
Ejemplares similares
-
Chronic Pain Treatment: The Influence of Tricyclic Antidepressants on Serotonin Release and Uptake in Mast Cells
por: Ferjan, Ilonka, et al.
Publicado: (2013) -
Impact of tricyclic antidepressants, selective serotonin reuptake inhibitors, and other antidepressants on overall survival of patients with advanced lung cancer from 2004 to 2014: University of Cincinnati experience
por: Abdel Karim, Nagla Fawzy, et al.
Publicado: (2019) -
Antitumoral Effects of Tricyclic Antidepressants: Beyond Neuropathic Pain Treatment
por: Asensi-Cantó, Antonio, et al.
Publicado: (2022) -
Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis
por: Wozniak, Greta, et al.
Publicado: (2011) -
Do the binding sites of substrates and tricyclic antidepressants overlap on the serotonin transporter?
por: Sarker, Subhodeep, et al.
Publicado: (2008)